Cellectric is a brand that is at the forefront of bridging the gap between electrodynamics and biology. Their mission is to revolutionize life science applications by making them faster, easier, and more precise through electrodynamic cell manipulation. By harnessing cutting-edge developments in material science, electrical engineering, and biotechnology, Cellectric is dedicated to shaping a better, healthier future for everyone.

Founded in 2021, Cellectric is currently focused on developing a platform that simplifies complex samples into simple, single-population solutions. Their current showcase is the isolation of viable bacteria from human samples, which greatly accelerates sepsis diagnosis. They have an exciting pipeline of proof-of-concept applications in the works, including the isolation of leukocytes from human whole-blood, leading to a customizable platform that separates increasingly similar mammalian cell populations at high throughput.

Their approach is fast, automated, and selective. Cellectric's journey has been marked by numerous accolades and awards, including the Falling Walls Young Innovator Award in 2013 and the Austrian Phönix Gründerpreis in 2021. With sepsis as their first business case, Cellectric aims to become the global leader in electrodynamic applications for biotechnology and bioelectric medicine.

The Cellectric team is comprised of highly skilled professionals with diverse expertise. Led by managing directors Klemens Wassermann and Terje Wimberger, the team includes individuals specializing in culture & lab management, engineering & development, cell- & microbiology, microfluidics & separation, and more. They are passionate about driving innovation and transforming the field of life sciences.

To stay updated with Cellectric's progress, you can subscribe to their newsletter or visit their website for the latest news and insights